- Home
- ICMB vs ICU Comparison
ICMB vs ICU Comparison
Compare ICMB & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICMB | ICU |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 13.8M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ICMB | ICU |
|---|---|---|
| Price | $0.87 | $3.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.3K | ★ 70.4K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | ★ 21.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,234,000.00 |
| Revenue This Year | $7.43 | $53.00 |
| Revenue Next Year | N/A | $50.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 814.07 |
| 52 Week Low | $0.73 | $0.22 |
| 52 Week High | $3.12 | $5.38 |
Technical Indicators
Market Signals| Indicator | ICMB | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 47.76 |
| Support Level | $0.86 | $2.21 |
| Resistance Level | $0.89 | $3.85 |
| Average True Range (ATR) | 0.05 | 0.25 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 78.21 | 49.44 |
Price Performance
Historical ComparisonAbout ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.